Nouri: independent guides
for GLP-1 weight loss

Free dose calculators, cost guides, and a side-by-side comparison of licensed options — for people who already have a GLP-1 prescription. We do not prescribe, dispense, or sell medication, and we are not accepting patients.

What we publish

Three things we publish, and nothing we sell.

Dose calculators, cost guides, and a comparison of licensed options — free, dated, and with the sources named. Nouri does not prescribe, dispense, or sell medication, and is not accepting patients.

Dose calculators

Convert a prescribed dose in milligrams into units on a U-100 insulin syringe, at any vial concentration. The tirzepatide dose calculator and the semaglutide dose calculator run entirely in your browser — nothing you type is sent anywhere, logged, or stored.

Licensed options

A side-by-side comparison of the companies we can verify, each with its own published cash price and the date we read it. FDA-approved and compounded, labelled and explained rather than ranked.

Nouri may earn a commission on some links in the comparison. It does not change which companies we list, the order they appear in, or the facts we report.

Learn more See pricing
How to use this site

From a dose on a vial to a price you can check.

A Nouri box beside a glass of water, towel, and vase on a sunlit bathroom counter.
01

Convert your dose.

Enter the dose your clinician prescribed and the concentration printed on your vial. The calculator returns the units to draw on a U-100 syringe. It converts a prescribed dose; it never chooses one.

~30 seconds
02

See what the next vial costs.

The comparison lists each licensed company's own published cash price, the date we read it, and what that price does and does not include.

~2 minutes
03

Read before you switch.

Prescriptions do not transfer between telehealth platforms. Find out what changes, what to bring to a new clinician, and what a low advertised rate assumes about how long you stay.

~5 minutes
How we work

An independent publisher, and what that obliges us to do.

01 What changed

Until 2026, Nouri ran a telehealth program.

An online questionnaire, a clinician review, and compounded semaglutide or tirzepatide shipped to the door. That program has closed. Nouri no longer prescribes, dispenses, or sells medication, is not accepting patients, and holds no patient records from it. If you were a customer and need something, write to care@joinnouri.com.

02 Who writes this

A named author, a credentialed reviewer, a date.

Articles are written by the Nouri Editorial Team and medically reviewed by Amber Patel, MD. Every health page carries the reviewer's name and the date it was last reviewed, so you can see how old a page is before you decide how much to trust it.

03 Where the numbers come from

Cited to the trial, or read off the company's own site.

Clinical figures are attributed to the trial or the regulator they came from. Prices are each company's own published cash price, read from its site on a date we print on the page. We re-check by hand roughly every 90 days, and we do not claim live pricing. The calculators run in your browser; nothing you type is sent anywhere.

04 How we're paid

Some links earn us a commission. We say so where they are.

That does not change which companies we list, the order they appear in, or the facts we report, and at least one company in every comparison pays us nothing and is labelled as such. The full disclosure names every commission-earning link, and it is repeated on the page where those links appear — never only in the footer.

05 What we will not say

No best, no cheapest, no safest, no scores.

We do not rank companies by merit, award stars, or call any provider or product the best, the cheapest, the safest or the most effective, because those are claims we cannot substantiate. We compare what can be checked: published price, what that price includes, whether the medication is FDA-approved or compounded, and who dispenses it. The five criteria that decide whether a company is listed at all are published on our editorial policy page. Every comparison we publish is held to this rule — see our provider reviews and comparisons or the compounded GLP-1 telehealth provider comparison.

Morning light across linen and a Nouri box, evoking starting from where you are.

Begin where you are.

FAQ

Your questions, answered

Nouri is an independent publisher. We build free dose calculators, write cost guides, and maintain a side-by-side comparison of licensed companies that prescribe GLP-1 medication. Nouri is not a telehealth service: it does not prescribe, dispense or sell medication, does not arrange prescriptions, and is not accepting patients. Some links in the comparison earn Nouri a commission, and we say so on the page where those links appear rather than only in the footer.
Dose decisions belong to the clinician who prescribes for you, and no website can make one. If you are moving between companies, bring your last three injection dates, your dose in milligrams, and the concentration printed on your vial. Concentration differs between pharmacies, so the number of units you draw can change even when your dose in milligrams does not — our dose calculators convert between the two, and they convert a prescribed dose rather than choosing one.
The Program has closed, and Nouri charges nothing. Everything we publish is free and there is no account to open. What the licensed companies in our comparison charge is a different question, answered on the weight loss page: each company's own published cash price, with the date we read it from their site. Published rates start at $99/mo for compounded semaglutide and $299/mo for Zepbound vials bought self-pay, and they change often.
Nouri has no results to report, because Nouri no longer treats anyone. The trial figures for the branded molecules — a mean of about 14.9% body-weight reduction on semaglutide 2.4 mg over 68 weeks, and about 20.9% on tirzepatide 15 mg over 72 weeks — are set out on our weight loss page with both trials cited. Those trials ran alongside diet and exercise, no compounded product has been tested in them, and individual results vary.
None. Nouri does not dispense medication and has no pharmacy. Each company in our comparison uses its own, and a company that will not name the pharmacy that dispenses its medication is excluded from the comparison entirely — that is one of five published criteria, applied before any commercial conversation. The criteria are set out in full on our editorial policy page.
Nouri does not ship anything. Availability by state is set by each company and changes; some require a video visit before a prescription can be written in certain states. Check on the company's own site before committing to a plan length, because a prepaid twelve-month rate is worth much less if the company cannot serve you where you live.
Nouri has no clinicians and provides no care. Our health pages are written by the Nouri Editorial Team and medically reviewed by Amber Patel, MD, who reviews the accuracy of what we publish and does not treat readers. Every health page carries the reviewer's name and the date it was last reviewed. Clinical decisions are made by the licensed clinician who has evaluated you.
No. Compounded therapies are not FDA-approved. They are prepared by state-licensed pharmacies based on a valid prescription from a licensed physician. The FDA does not verify their safety, effectiveness or quality, and they are not therapeutically equivalent to the approved brand-name products.
No. Nouri does not prescribe, dispense or sell medication, and is not accepting patients. It publishes calculators, cost guides, and a comparison of licensed companies. Prescribing decisions are made by licensed clinicians who have evaluated the individual patient.
Not Nouri. Compounded medication is prepared by a state-licensed compounding pharmacy working for the company that took your prescription. That is why the comparison states the dispensing arrangement on each entry, and why a company that will not name its pharmacy is not listed.